Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil. [electronic resource]
Producer: 20100421Description: 191-9 p. digitalISSN:- 1678-4391
- Adult
- Antiviral Agents -- administration & dosage
- Cost-Benefit Analysis
- Drug Therapy, Combination
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Markov Chains
- Polyethylene Glycols -- administration & dosage
- Quality of Life
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.